Warren Stone

Chief Commercial OfficeratNeogenomics· In proxies 2021–2025

Pay in FY2025+59% from the year before · Neogenomics stock -28.6% the same year

Warren Stone was paid $5.1M in FY2025 (Dec), up 59%. Neogenomics stock fell 28.6% that year.

Pay$100 in the stock at the end of FY20 → $22

Pay is from the Summary Compensation Table of each Neogenomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

NeogenomicsPublic company · 5 yr
- Chief Commercial Officer2021 – Present · 5 yrStock in role -68%

Roles come from the proxy statements of each company.

Activity

Pay
Neogenomics Division head pay rose 59% to $5.1M. The stock fell 29% in FY2025 (Dec).
DEF 14AApr 6, 2026
Pay
Neogenomics Division head pay rose 26% to $3.0M. The stock rose 75% in FY2023 (Dec).
DEF 14AApr 8, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?